Eikmans M, van der Keur C, Anholts J, Drabbels J, van Beelen E, de Sousa Lopes S, et al. Primary Trophoblast Cultures: Characterization of HLA Profiles and Immune Cell Interactions. Front Immunol. 2022;13:814019 pubmed 出版商

Sreevalsan S, Döring M, Paszkowski Rogacz M, Brux M, Blanck C, Meyer M, et al. MLLT6 maintains PD-L1 expression and mediates tumor immune resistance. EMBO Rep. 2020;:e50155 pubmed 出版商

Ninio Many L, Hikri E, Burg Golani T, Stemmer S, Shalgi R, Ben Aharon I. miR-125a Induces HER2 Expression and Sensitivity to Trastuzumab in Triple-Negative Breast Cancer Lines. Front Oncol. 2020;10:191 pubmed 出版商

Robichaux J, Elamin Y, Vijayan R, Nilsson M, Hu L, He J, et al. Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity. Cancer Cell. 2019;36:444-457.e7 pubmed 出版商

Durst F, Grujovic A, Ganser I, Hoffmann M, Ugocsai P, Klein C, et al. Targeted transcript quantification in single disseminated cancer cells after whole transcriptome amplification. PLoS ONE. 2019;14:e0216442 pubmed 出版商

Baccelli I, Gareau Y, Lehnertz B, Gingras S, Spinella J, Corneau S, et al. Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia. Cancer Cell. 2019;36:84-99.e8 pubmed 出版商